The “New Normal” & the Civil Society Deception
Representative democracy is quietly being phased out to be replaced with a “new normal.” This “new normal” is a nascent form of governance
Representative democracy is quietly being phased out to be replaced with a “new normal.” This “new normal” is a nascent form of governance
English Español (Spanish) Representative democracy is quietly being phased out to be replaced with a “new normal.” This “new normal”
By RICK BRUNDRETT Last week, a legislatively controlled committee quietly approved five-figure salary hikes for six state agency heads, including
By RICK BRUNDRETT Nearly half of South Carolina’s 46 counties were charging annual road maintenance fees as of last December, records show, though
By RICK BRUNDRETT Lawmakers just can’t resist trying to exert more power over another branch of government. Reps. John King, D-York; Annie
By RICK BRUNDRETT When it comes to South Carolina history, some state officials might need a refresher course. S.C. taxpayers are on the hook for
By RICK BRUNDRETT Another year, another round of raises for higher-paid S.C. House and Senate staffers. The Nerve’s review of chamber records
On Wednesday, an “industry-led and UN-convened” alliance of private banking and financial institutions announced plans at the COP26 conference
On Wednesday, an “industry-led and UN-convened” alliance of private banking and financial institutions announced plans at the COP26 conference
Back in February 2021, the American Federation of Teachers (AFT) and the National Education Association (NEA) lobbied the Centers for Disease Control
Back in February 2021, the American Federation of Teachers (AFT) and the National Education Association (NEA) lobbied the Centers for Disease Control
By RICK BRUNDRETT As a special legislative panel considers a yet-to-be-revealed road funding proposal, the state Department of Transportation
By RICK BRUNDRETT Hugh Weathers, South Carolina’s agriculture commissioner, dubbed the project as the “Boeing of agriculture.” In touting
In late 2019, the biopharmaceutical company Moderna was facing a series of challenges that not only threatened its ability to ever take a product to
By RICK BRUNDRETT Once again, the state’s chief revenue forecasters have grossly overestimated the popularity of an income tax credit that